Bower raises $2M to build AI for the research lab

Bower has raised $2 million in pre-seed funding to expand its ambient-intelligence platform for scientists, with backing from TEN13, Admiralty Capital Group, Edale Capital and angels. The Gold Coast startup is targeting a gap in research: capturing what happens at the bench so experiments can be reproduced, transferred and accelerated.

Why it matters: - Bower is trying to solve a core research bottleneck: most lab knowledge is still trapped in notebooks, spreadsheets, paper files or individual researchers’ heads. - The company’s pitch is that better capture of experimental decisions and observations can improve reproducibility, speed up technology transfer and make R&D easier to scale. - The stakes are high. The release cites a reproducibility crisis in biomedicine, multi-month tech-transfer delays and billions of dollars in annual waste from irreproducible preclinical research.

What happened: - Bower, a Gold Coast-based company building what it calls the operating system for research, raised $2 million in pre-seed funding. - Brisbane-based TEN13 led the round. - Admiralty Capital Group, Edale Capital and angel investors also participated. - Angel backers include Yu Liu, CTO of Heidi Health, Dean Kelly, Harry Uffindell and Emma Ferrier. - Strategic advisor Bernhard Hans Weigl also backed the company.

The details: - Bower is building AI for the lab, which it describes as a new category called augmented research. - The platform uses smart glasses, mobile and desktop tools to work alongside scientists during experiments. - Bower captures what researchers see, say, observe and decide, then automates documentation without pulling them out of the workflow. - The system turns those interactions into structured, searchable organizational knowledge that can be used by both scientists and AI. - Bower then brings that knowledge back into the lab by surfacing prior work, guiding procedures and answering questions during later experiments. - The company says the result is a feedback loop in which each experiment makes the organization smarter and improves the next one. - Bower says its platform is designed for human-led research teams, not fully autonomous labs. - The company says the product is meant to amplify the scientist rather than replace the scientist.

Between the lines: - Bower is positioning itself closer to ambient clinical documentation tools than to robotics-first lab automation. - That matters because most research environments are still human-operated, and the biggest loss is often not execution, but the failure to preserve context. - The company is also aiming at a broader shift in AI for science: models may be getting stronger at reasoning, but they still need better real-world lab input. - Bower’s argument is that the missing layer is not more analysis on top of science, but better capture of what actually happens during science.

What’s next: - Over the next six months, Bower plans to work toward a PPE-certified wearables partnership with its design partners. - The company then expects to scale the product over the following six months. - Early customers already include Mount Sinai Hospital in New York City, Mass Affinity, Bloodless Diagnostics and Southern Cross University. - The company is also expanding with a team that includes Michelle MacRae, David Lyon, James Boysons and Renaud Joannes-Boyau.

The bottom line: - Bower is betting that the next big productivity gain in science will come from capturing lab knowledge at the moment it is created, not after the experiment ends. - If that works, the payoff is not just better documentation. It is a faster, more reproducible research system.